About Nimodipine
Class: | Calcium channel blocker
Use: | Nimodipine is primarily used for the prevention and treatment of cerebral vasospasm following subarachnoid hemorrhage. It may also be used off-label for other conditions involving cerebral ischemia.
Adult dose: | The standard adult dosing for nimodipine is 30 mg every 4 hours for 21 consecutive days, administered orally. For intravenous infusion, the recommended dose is typically 1-2 mg/hour, but specific dosing may vary based on clinical judgment and
Drug Class
Calcium channel blocker
Uses & Indications
Nimodipine is primarily used for the prevention and treatment of cerebral vasospasm following subarachnoid hemorrhage. It may also be used off-label for other conditions involving cerebral ischemia.
Storage Requirements
Store at room temperature (20-25°C or 68-77°F) in a protected environment, away from light. Do not freeze. Once opened, the solution should be used within 24 hours.
Manufacturer & Packaging
Manufacturer: United Biotech, India
Package Size
50 ml
Price & Supplier
Price in UAE: AED 89.60
Dosage Information
Adult Dose
The standard adult dosing for nimodipine is 30 mg every 4 hours for 21 consecutive days, administered orally. For intravenous infusion, the recommended dose is typically 1-2 mg/hour, but specific dosing may vary based on clinical judgment and patient response.
Pediatric Dose
Safety and efficacy in pediatric patients have not been established; therefore, nimodipine is generally not recommended for use in children.
Side Effects
Common side effects include hypotension, headache, nausea, diarrhea, flushing, and dizziness. Rare but serious side effects may include severe hypotension and allergic reactions.
Contraindications & Precautions
Nimodipine is contraindicated in patients with a known hypersensitivity to the drug or its components, and in patients with severe hypotension or cardiogenic shock. It should not be administered intravenously in a manner that could lead to rapid bolus administration.
Important Warnings
Important safety warnings include the risk of hypotension, especially in patients with compromised cardiovascular function. Caution is advised when administering to patients with hepatic impairment, as dose adjustments may be necessary. Additionally, nimodipine should not be used in conjunction with other intravenous calcium channel blockers.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.